Search alternatives:
ms decrease » _ decrease (Expand Search), use decreased (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ms decrease » _ decrease (Expand Search), use decreased (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
37421
-
37422
-
37423
Random effects and model fitness.
Published 2023“…A total of 5,527 (weighted) live births were included in the analysis. …”
-
37424
Δ40p53 alters WTp53 function; Δ40p53:WTp53 fails to induce eRNA transcription despite similar genomic occupancy vs. WTp53.
Published 2021“…<p><b>(A)</b> Summary of PRO-seq data for WTp53 (y-axis) vs. …”
-
37425
-
37426
-
37427
-
37428
-
37429
-
37430
Sleep quality of respondents (n = 259).
Published 2025“…Excessive use of screen devices has resulted in decreased sleep and had a negative impact on mental health of adolescents. …”
-
37431
Mental health status of respondents (n = 259).
Published 2025“…Excessive use of screen devices has resulted in decreased sleep and had a negative impact on mental health of adolescents. …”
-
37432
-
37433
-
37434
-
37435
The embryonic zebrafish trunk is perfused by a series of parallel intersegmental arteries (SeAs).
Published 2017“…<p>Hydraulic models for the network predict that the first of these SeA will short circuit flow through the trunk. (A) 4 day post-fertilization zebrafish embryo trunk network and wiring diagram showing PCV, DA and Se vessels in which SeA connect directly to SeV. …”
-
37436
Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-co...
Published 2018“…Adverse events were observed in 30%–50% of patients (all groups). Incidence of adverse events was similar among all groups except for decreased calcium, which occurred more frequently in the evocalcet 2 mg and cinacalcet groups.…”
-
37437
-
37438
-
37439
-
37440